Mersana Therapeutics Inc (MRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 107,750 | 174,561 | 128,885 | 177,947 | 255,094 |
| Marketable Securities | 26,870 | 34,523 | 151,827 | N/A | N/A |
| Receivables | N/A | N/A | 30,000 | N/A | N/A |
| TOTAL | $136,904 | $214,057 | $319,219 | $188,898 | $258,580 |
| Non-Current Assets | |||||
| PPE Net | 2,203 | 3,831 | 3,985 | 1,968 | 1,730 |
| Other Non-Current Assets | 5,556 | 8,172 | 11,136 | 15,245 | 13,089 |
| TOTAL | $7,759 | $12,003 | $15,121 | $17,213 | $14,819 |
| Total Assets | $144,663 | $226,060 | $334,340 | $206,111 | $273,399 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,500 | 2,083 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,330 | 7,319 | 13,951 | 12,321 | 8,340 |
| Accrued Expenses | 18,964 | 21,898 | 43,184 | 28,716 | 16,146 |
| Other current liabilities | 640 | 938 | 990 | 239 | 93 |
| TOTAL | $62,458 | $63,637 | $91,533 | $47,523 | $30,003 |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,950 | 23,148 | 24,929 | 24,626 | 4,977 |
| Deferred Revenues | 22,168 | 28,147 | 30,610 | 3,944 | 3,987 |
| Other Non-Current Liabilities | 1,300 | 5,204 | 8,778 | 12,221 | 10,332 |
| TOTAL | $91,714 | $125,519 | $150,750 | $36,847 | $15,309 |
| Total Liabilities | $154,172 | $189,156 | $242,283 | $84,370 | $45,312 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,985 | 4,852 | 4,321 | 3,336 | 2,762 |
| Common Shares | 12 | 12 | 11 | 7 | 7 |
| Retained earnings | -895,553 | -826,361 | -654,691 | -450,479 | -280,419 |
| Other shareholders' equity | 10 | 11 | -152 | 0 | 0 |
| TOTAL | $-9,509 | $36,904 | $92,057 | $121,741 | $228,087 |
| Total Liabilities And Equity | $144,663 | $226,060 | $334,340 | $206,111 | $273,399 |